Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

16 juin 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Present at JMP Securities Life Sciences Conference

RADNOR, Pa., June 16, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today...
18 mai 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Presents Clinical Data of Ganaxolone in Pediatric Epilepsies at Antiepileptic Drug and Device Trials XIII Conference

RADNOR, Pa., May 18, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative epilepsy and other neuropsychiatric...
11 mai 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2015 Financial Results

RADNOR, Pa., May 11, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative epilepsy and other neuropsychiatric...
25 mars 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals' Ganaxolone Receives FDA Orphan Drug Designation in PCDH19 Female Epilepsy

RADNOR, Pa., March 25, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today...
16 mars 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Participate in Future Leaders in the Biotech Industry Conference

RADNOR, Pa., March 16, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today...
12 mars 2015 16h00 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Provides Business Update and Reports Year End 2014 Financial Results

RADNOR, Pa., March 12, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative epilepsy and other neuropsychiatric...
24 févr. 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Participate in Cowen & Company Annual Healthcare Conference

RADNOR, Pa., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today...
09 févr. 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Participate in Leerink Global Healthcare Conference

RADNOR, Pa., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today...
03 févr. 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Initiates Clinical Trial With Ganaxolone in PCDH19 Female Pediatric Epilepsy

RADNOR, Pa., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics,...
02 févr. 2015 07h30 HE | Source: Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals to Present at BIO CEO & Investor Conference

RADNOR, Pa., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today...

Page précédente